MICHELLE PALUMBO: Open Payments
NPI 1497534705 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 29 payments from 12 companies in 2025. Trend: 2023 $125 · 2024 $836 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $290 |
| LEO Pharma Inc. | 4 | $189 |
| Incyte Corporation | 1 | $123 |
| Novo Nordisk Inc | 1 | $123 |
| ABBVIE INC. | 5 | $105 |
| Janssen Biotech, Inc. | 2 | $70 |
| Lilly USA, LLC | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Dexcom, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: CIBINQO, ANZUPGO, Opzelura, Ozempic, RYBREVANT, RINVOQ, COSENTYX, QULIPTA.
Industry payments across NY — which companies pay providers there.
